H.C. Wainwright Adjusts Price Target on Acurx Pharmaceuticals to $12 From $14, Keeps Buy Rating
MT NewswiresMar 19 09:32 ET
Acurx Pharmaceuticals Analyst Ratings
BenzingaMar 19 06:27 ET
HC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $14 Price Target
BenzingaFeb 28 12:53 ET
Buy Rating for Acurx Pharmaceuticals Amid Promising Phase 2 Results and Positive Regulatory Momentum
TipRanksFeb 28 06:39 ET
Analysts' Top Healthcare Picks: Acurx Pharmaceuticals (ACXP), Champions Oncology (CSBR)
TipRanksJan 22 13:21 ET
Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH), Lisata Therapeutics (LSTA) and Acurx Pharmaceuticals (ACXP)
TipRanksJan 22 12:31 ET
HC Wainwright & Co. Maintains Buy on Acurx Pharmaceuticals, Raises Price Target to $14
BenzingaDec 15, 2023 06:36 ET
Acurx Pharmaceuticals Analyst Ratings
BenzingaDec 15, 2023 06:35 ET
Promising Future for Acurx Pharmaceuticals: A Buy Rating Backed by Strong Financials, Successful Clinical Trials, and Strategic Market Positioning
TipRanksNov 15, 2023 12:15 ET
Acurx Pharmaceuticals Analyst Ratings
BenzingaNov 15, 2023 10:22 ET
Promising Trials and Undervaluation Make Acurx Pharmaceuticals a Buy: An Analysis of ACXP's Potential
TipRanksNov 3, 2023 11:35 ET
Buy Rating on Acurx Pharmaceuticals: Promising Clinical Results and Financial Stability Highlighted by Analyst Ed Arce
TipRanksNov 2, 2023 12:39 ET
Maxim Raises Price Target on Acurx Pharmaceuticals to $10 From $7, Keeps Buy Rating
MT NewswiresOct 11, 2023 12:56 ET
Analysts Offer Insights on Healthcare Companies: PDS Biotechnology (PDSB) and Acurx Pharmaceuticals (ACXP)
TipRanksOct 2, 2023 11:40 ET
H.C. Wainwright Sticks to Its Buy Rating for Acurx Pharmaceuticals (ACXP)
TipRanksSep 13, 2023 06:25 ET
Acurx Pharmaceuticals Analyst Ratings
BenzingaSep 13, 2023 06:24 ET
Maxim Group Remains a Buy on Acurx Pharmaceuticals (ACXP)
TipRanksAug 15, 2023 14:45 ET
HC Wainwright & Co. Maintains Buy on Acurx Pharmaceuticals, Lowers Price Target to $13
BenzingaAug 15, 2023 07:15 ET
Acurx Pharmaceuticals Analyst Ratings
BenzingaAug 15, 2023 07:13 ET
H.C. Wainwright Reaffirms Their Buy Rating on Acurx Pharmaceuticals (ACXP)
TipRanksAug 15, 2023 06:35 ET
No Data
No Data